| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |